New Delhi: AYUSH Ministry in association with the Health Ministry has launched the clinical research studies on use of Ayurveda as preventive and add-on curative medicine for COVID-19.
The Interdisciplinary Ayush R&D Task Force has formulated and designed clinical research protocols for prophylactic studies and add-on interventions in COVID-19 positive cases through thorough review and consultative process of experts of high repute from different organisations across the country for studying four different interventions viz. Ashwagandha, Yashtimadhu, Guduchi +Pippali and a poly herbal formulation (AYUSH-64).
These studies will be done as a joint initiative of Ministry of AYUSH, Ministry of Health and the Ministry of Science and Technology through Council of Scientific & Industrial Research (CSIR) with technical support of ICMR.
AYUSH minister Shripad Naik and Health Minister Harsh Vardhan jointly launched the interdisciplinary study along with Secretary AYUSH , Vaidya Rajesh Kotecha.
An Interdisciplinary Ayush Research and Development Task Force with a group of experts under Vice Chairman, University Grant Commission (UGC) , Dr Bhushan Patvardhan has also been set up to formulate and develop strategies for these AYUSH based clinical studies.
The collaboration would also undertake population-based interventional studies on the impact of AYUSH based preventive medicines.
Assessment of acceptance and usage of AYUSH advisories in prevention of COVID-19 through AYUSH Sanjivani App would also be done.